0001477932-24-003422.txt : 20240531 0001477932-24-003422.hdr.sgml : 20240531 20240531154729 ACCESSION NUMBER: 0001477932-24-003422 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240531 DATE AS OF CHANGE: 20240531 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioNexus Gene Lab Corp CENTRAL INDEX KEY: 0001737523 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 262124961 STATE OF INCORPORATION: WY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41750 FILM NUMBER: 241009410 BUSINESS ADDRESS: STREET 1: 10-2 TOWER B, VERTICAL BUSINESS SUITE, STREET 2: 8 JALAN KERINCHI, CITY: KUALA LUMPUR STATE: N8 ZIP: 59200 BUSINESS PHONE: 1-307-241-6898 MAIL ADDRESS: STREET 1: 10-2 TOWER B, VERTICAL BUSINESS SUITE, STREET 2: 8 JALAN KERINCHI, CITY: KUALA LUMPUR STATE: N8 ZIP: 59200 FORMER COMPANY: FORMER CONFORMED NAME: BioNexus Gene Lab Coporation DATE OF NAME CHANGE: 20180413 10-K/A 1 bglc_10ka.htm FORM 10-K/A bglc_10ka.htm

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

WASHINGTON, DC 20549

 

Amendment No.1

FORM 10-K/A

 

(Mark One)

 

ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended: December 31, 2023

 

or

 

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________

 

Commission File Number: 001-41750

 

BIONEXUS GENE LAB CORP.

(Exact name of registrant as specified in its charter)

 

Wyoming

 

35-2604830

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

 

 

 

Unit 02, Level 10, Tower B, Avenue 3, The Vertical

 

 

Business Suite II, Bangsar South

 

 

8 Jalan Kerinchi

 

 

Kuala Lumpur, Malaysia

 

59200

(Address of Principal Executive Offices)

 

(Zip Code)

 

+1 307 241 6898 

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading Symbol(s)

 

Name of each exchange where registered

Common Stock, no par value

 

BGLC

 

Nasdaq Capital Market

 

Securities registered pursuant to Section 12(g) of the Act: 

None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer

Accelerated filer

Non-accelerated Filer

Smaller reporting company

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No ☒

 

As of June 30, 2023, the aggregate market value of the registrant’s common stock held by non-affiliates of the registrant was approximately $66.5 million (this amount represents approximately 25.1 million shares of BioNexus Gene Lab Corp’s common stock based on the last reported sales price of $2.6521 of the common stock on such date).

 

As of December 31, 2023, there were 17,667,663 shares of common stock, no par value, outstanding.

 

 

 

 

Explanatory Note

 

This Amendment No. 1 on Form 10-K/A (the “Amendment”) amends the Annual Report on Form 10-K of BioNexus Gene Lab Corp. (the “Company”) for the fiscal year ended December 31, 2023 (the “Original Filing”). This Amendment is being filed solely to amend and restate in its entirety Part II., Item 9A. Controls and Proceduresof the Prior Filing.

 

This filing is in response to a Comment Letter from the Staff of the Securities and Exchange Commission.

 

Other than as expressly set forth herein, this Amendment does not, and does not purport to, amend, update or restate the information in the Original Filing or reflect any events that have occurred after the Original Filing was made. Information not affected by this Amendment remains unchanged and reflects the disclosures made at the time as of which the Original Filing was made. No changes have been made to the financial statements of the Company as contained in the Original Filing. Accordingly, this Amendment should be read together with the Original Filing and the Company’s other filings with the SEC.

 

Item 9A. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

In connection with the preparation of this annual report, an evaluation was carried out by the Company’s management, with the participation of the principal executive officer and the principal financial officer, of the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act (“Exchange Act”) as of December 31, 2023. Disclosure controls and procedures are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Commission’s rules and forms, and that such information is accumulated and communicated to management, including the principal executive officer and the principal financial officer, to allow timely decisions regarding required disclosures.

 

Based on that evaluation, the Company’s management concluded, as of the end of the period covered by this report, that the Company’s disclosure controls and procedures were not effective in recording, processing, summarizing, and reporting information required to be disclosed, within the time periods specified in the Commission’s rules and forms, and that such information was not accumulated and communicated to management, including the principal executive officer and the principal financial officer, to allow timely decisions regarding required disclosures. The Company’s disclosure controls and procedures were not effective due to the fact in Part II., Item 9A. Controls and Procedures in the Original Filing, as management did not reach a conclusion on the effectiveness of the controls and procedures.

 

Management’s Report on Internal Control over Financial Reporting

 

The management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting. The Company’s internal control over financial reporting is a process, under the supervision of the principal executive officer and the principal financial officer, designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the Company’s financial statements for external purposes in accordance with United States generally accepted accounting principles (GAAP). Internal control over financial reporting includes those policies and procedures that:

 

·

Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the Company’s assets;

 

·

Provide reasonable assurance that transactions are recorded as necessary to permit preparation of the financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures are being made only in accordance with authorizations of management and the board of directors; and

 

·

Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

 

 
2

 

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

 

The Company’s management conducted an assessment of the effectiveness of our internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013) as set forth in its Internal Control - Integrated Framework. This assessment concluded that the internal control over financial reporting were effective.

 

In reaching its conclusion, management considered the potential material weakness due to the lack of segregation of duties between the Chief Executive Officer and Chief Financial Officer as the same person currently fulfils both roles. However, when the former Chief Financial Officer resigned in October 2023, the Audit Committee working with management installed additional controls whereby the Audit Committee Chairman would have access to financial reports on a regular and at will basis. In addition, since that time, the Audit Committee Chairman conducts regular interviews with the Principal Financial Officer to ensure adequate oversight over the financial process. Finally, as the Company conducts its business mainly through its subsidiaries, there are sufficient and separate accounting staff in each of its subsidiaries to maintain an effective segregation of duties, and oversight by the Management and the Audit Committee.

 

This annual report does not include an attestation report of our registered public accounting firm regarding our internal controls over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to Section 404(c) of the Sarbanes-Oxley Act that permit us to provide only management’s report in this annual report.

 

Changes in Internal Controls over Financial Reporting

 

During the year ended December 31, 2023, there has been no change in internal control over financial reporting that has materially affected or is reasonably likely to materially affect our internal control over financial reporting.

 

 
3

 

 

Item 6. Exhibits.

 

Exhibit

 

Description

 

 

 

31.1

 

Certification of the Company’s Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL Document)

 

 
4

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

BIONEXUS GENE LAB CORPORATION

 

 

 

/s/ Su-Leng Tan Lee

 

Su-Leng Tan Lee

 

Chief Executive Officer

(Principal Executive Officer)

 

 

 

/s/ Su-Leng Tan Lee

 

Su-Leng Tan Lee

 

Acting Chief Financial Officer

(Acting Principal Financial and Accounting Officer)

 

 May 31, 2024

 

 
5

 

EX-31.1 2 bglc_ex311.htm CERTIFICATION bglc_ex311.htm

EXHIBIT 31.1

 

CERTIFICATION

 

I, Su-Leng Tan Lee, certify that:

 

1.

I have reviewed this Annual Report on Form 10-K/A of Bionexus Gene Lab Corporation (the “Registrant”), for the fiscal year ended December 31, 2023;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, considering the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

[Paragraph intentionally omitted];

 

 

4.

I am the Registrant’s sole certifying officer and am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

(c)

Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

(d)

Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

 

5.

I am the Registrant’s sole certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

Dated: May 31, 2024

By:

/s/ Su-Leng Tan Lee

 

 

 

Su-Leng Tan Lee

 

 

 

Chief Executive Officer

 

 

 

(Principal Executive Officer)

and

Acting Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

EX-101.SCH 3 bglc-20231231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 bglc-20231231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Voluntary Filers Current Fiscal Year End Date Entity Well Known Seasoned Issuer Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Ex Transition Period Entity Common Stock Shares Outstanding Entity Public Float Document Annual Report Document Transition Report Document Fin Stmt Error Correction Flag Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Address Line 1 Entity Address Address Line 2 Entity Address Address Line 3 Entity Address City Or Town Entity Address Country Entity Address Postal Zip Code City Area Code Amendment Description Icfr Auditor Attestation Flag Local Phone Number Security 12b Title Trading Symbol Security Exchange Name Entity Interactive Data Current EX-101.CAL 5 bglc-20231231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 6 bglc-20231231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 7 bglc-20231231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 9 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Jun. 30, 2023
Cover [Abstract]    
Entity Registrant Name BIONEXUS GENE LAB CORP.  
Entity Central Index Key 0001737523  
Document Type 10-K/A  
Amendment Flag true  
Entity Voluntary Filers No  
Current Fiscal Year End Date --12-31  
Entity Well Known Seasoned Issuer No  
Entity Small Business true  
Entity Shell Company false  
Entity Emerging Growth Company true  
Entity Current Reporting Status Yes  
Document Period End Date Dec. 31, 2023  
Entity Filer Category Non-accelerated Filer  
Document Fiscal Period Focus FY  
Document Fiscal Year Focus 2023  
Entity Ex Transition Period false  
Entity Common Stock Shares Outstanding 17,667,663  
Entity Public Float   $ 66.5
Document Annual Report true  
Document Transition Report false  
Document Fin Stmt Error Correction Flag false  
Entity File Number 001-41750  
Entity Incorporation State Country Code WY  
Entity Tax Identification Number 35-2604830  
Entity Address Address Line 1 Unit 02, Level 10, Tower B, Avenue 3, The Vertical  
Entity Address Address Line 2 Business Suite II, Bangsar South  
Entity Address Address Line 3 8 Jalan Kerinchi  
Entity Address City Or Town Kuala Lumpur  
Entity Address Country MY  
Entity Address Postal Zip Code 59200  
City Area Code 307  
Amendment Description This Amendment No. 1 on Form 10-K/A (the “Amendment”) amends the Annual Report on Form 10-K of BioNexus Gene Lab Corp. (the “Company”) for the fiscal year ended December 31, 2023 (the “Original Filing”). This Amendment is being filed solely to amend and restate in its entirety Part II., Item 9A. Controls and Proceduresof the Prior Filing.  
Icfr Auditor Attestation Flag false  
Local Phone Number 241 6898  
Security 12b Title Common Stock, no par value  
Trading Symbol BGLC  
Security Exchange Name NASDAQ  
Entity Interactive Data Current Yes  
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 3 38 1 false 0 0 false 3 false false R1.htm 000001 - Document - Cover Sheet http://bglc.com/role/Cover Cover Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, dei:DocumentFinStmtErrorCorrectionFlag - bglc_10ka.htm 1 bglc-20231231.xsd bglc-20231231_cal.xml bglc-20231231_def.xml bglc-20231231_lab.xml bglc-20231231_pre.xml bglc_10ka.htm http://xbrl.sec.gov/dei/2023 true true JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "bglc_10ka.htm": { "nsprefix": "bglc", "nsuri": "http://bglc.com/20231231", "dts": { "schema": { "local": [ "bglc-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "bglc-20231231_cal.xml" ] }, "definitionLink": { "local": [ "bglc-20231231_def.xml" ] }, "labelLink": { "local": [ "bglc-20231231_lab.xml" ] }, "presentationLink": { "local": [ "bglc-20231231_pre.xml" ] }, "inline": { "local": [ "bglc_10ka.htm" ] } }, "keyStandard": 38, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 6, "http://xbrl.sec.gov/dei/2023": 6 }, "contextCount": 3, "entityCount": 1, "segmentCount": 0, "elementCount": 39, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 38 }, "report": { "R1": { "role": "http://bglc.com/role/Cover", "longName": "000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "bglc_10ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "bglc_10ka.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r3", "r4", "r5" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fin Stmt Error Correction Flag", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r3", "r4", "r5", "r7" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r6" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 1", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 2", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 3", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address City Or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r10" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r1" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r8" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r1" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well Known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r9" ] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Icfr Auditor Attestation Flag" } } }, "auth_ref": [ "r3", "r4", "r5" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://bglc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 18 0001477932-24-003422-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001477932-24-003422-xbrl.zip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end XML 20 bglc_10ka_htm.xml IDEA: XBRL DOCUMENT 0001737523 2023-01-01 2023-12-31 0001737523 2023-12-31 0001737523 2023-06-30 iso4217:USD shares iso4217:USD shares 0001737523 true --12-31 FY 2023 false 10-K/A true 2023-12-31 false 001-41750 BIONEXUS GENE LAB CORP. WY 35-2604830 Unit 02, Level 10, Tower B, Avenue 3, The Vertical Business Suite II, Bangsar South 8 Jalan Kerinchi Kuala Lumpur MY 59200 307 241 6898 Common Stock, no par value BGLC NASDAQ No No Yes Yes Non-accelerated Filer true true false false false 66500000 17667663 This Amendment No. 1 on Form 10-K/A (the “Amendment”) amends the Annual Report on Form 10-K of BioNexus Gene Lab Corp. (the “Company”) for the fiscal year ended December 31, 2023 (the “Original Filing”). This Amendment is being filed solely to amend and restate in its entirety Part II., Item 9A. Controls and Proceduresof the Prior Filing.